Express News | Summary of Shareholding changes on December 20.

BreakingsDec 20 22:26

Express News | Beijing Wantai Biological Pharmacy Enterprise: Executives plan to reduce shareholding by no more than 400,000 shares.

BreakingsDec 20 19:29

Wantai Gets Clinical Trial Approval for HPV Vaccine for Men

MT NewswiresNov 19 11:56

Express News | Beijing Wantai Biological Pharmacy Enterprise: Notification of Approval of Clinical Trial Application for Nine-Valent HPV Vaccine in Males.

BreakingsNov 18 17:27

Beijing Wantai Biological Pharmacy Enterprise (603392.SH): The company currently has no plans to produce the non-segmented HPV vaccine.

Gelonghui, November 7th | Beijing Wantai Biological Pharmacy Enterprise (603392.SH) stated on the interactive platform that there is currently no plan for segmented production of the company's nine-valent HPV vaccine.

Gelonghui FinanceNov 7 16:49

Beijing Wantai Biological Pharmacy Enterprise (603392.SH): The phase II expansion project of the nine-valent cervical cancer vaccine is proceeding as planned, with the main equipment procurement and workshop purification decoration completed.

Gelonghui November 7th | beijing wantai biological pharmacy enterprise (603392.SH) stated on the interactive platform that the second phase expansion project of the nine-valent cervical cancer vaccine is progressing as planned, with the main equipment procurement and workshop purification renovation completed, and equipment commissioning and verification work underway. In addition to the flagship product, the nine-valent HPV vaccine, the company's other research and development projects are progressing in an orderly manner.

Gelonghui FinanceNov 7 16:45